# Cognitive Enhancement in Bipolar Disorder

> **NCT00597896** · PHASE4 · COMPLETED · sponsor: **Northwell Health** · enrollment: 50 (actual)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** pramipexole

## Key facts

- **NCT ID:** NCT00597896
- **Lead sponsor:** Northwell Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2015-06-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00597896

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00597896, "Cognitive Enhancement in Bipolar Disorder". Retrieved via AI Analytics 2026-09-09 from https://api.ai-analytics.org/clinical/NCT00597896. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*